We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ITOX market cap is 305.11k. The company's latest EPS is USD -0.0026 and P/E is 0.00.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 225k | 147k | 37k | 11k | 89k |
| Operating Income | -1.32M | -1.86M | -1.03M | -880k | -655k |
| Net Income | -1.61M | -1.89M | -2.24M | -1.06M | -1.08M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 524k | 453k | 453k | 364k | 514k |
| Total Liabilities | 1.06M | 2.37M | 2.81M | 1.44M | 1.78M |
| Total Equity | -540k | -1.92M | -2.54M | -1.27M | -1.81M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -522k | -325k | -117k | -628k | -657k |
| Investing | N/A | N/A | N/A | N/A | -200k |
| Financing | 500k | 310k | 196k | 572k | 843k |
| Market Cap | 305.11k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 406.82M |
| Average Volume (1 week) | 1.53M |
| Average Volume (1 Month) | 1.41M |
| 52 Week Change | -50.00% |
| 52 Week High | 0.0029 |
| 52 Week Low | 0.0005 |
| Spread (Intraday) | 0 (14.29%) |
| Company Name | IIOT OXYS Inc (PK) |
| Address |
680 w nye lane carson city, nevada 89703 |
| Website | https://www.oxyscorp.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
